Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
RSNA 2025
Contact
  • Home
  • /
  • Resources
  • /
  • Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study

Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study

  • Category: Published research
  • Product: NeuroQuant MS
  • Disease: Multiple sclerosis

This study compares clinical and MRI parameters between patients with clinically isolated syndrome and those converting to clinically definite multiple sclerosis within 2 years, to identify volumetric MRI predictors of this conversion and to assess effect of early relapses. 2012.

[button]Download[/button]

  • Topic: Published research

More Resources

Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
  • 2 mins

04/10/2026

OnQ Prostate Vendor Validation: From Research to Clinical Adoption

OnQ Prostate delivers consistent, reliable AI-powered prostate MRI insights across vendors, ensuring confident diagnosis and streamlined clinical workflows.

Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
  • 3 mins

03/20/2026

Quantitative MRI, the McDonald Criteria, and the Future of Multiple Sclerosis Care

MRI is the foundation for diagnosing and monitoring multiple sclerosis (MS)

Cortechs Cares: Community Impact and Volunteer Efforts in 2025
  • 2 mins

03/13/2026

Cortechs Cares: Community Impact and Volunteer Efforts in 2025

Cortechs Cares highlights how our team gave back in 2025 through community volunteer efforts, including an Alzheimer’s Walk and holiday toy drive.

Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
  • 2 mins

03/11/2026

OnQ™ Prostate: Bringing Quantitative MRI to Prostate Imaging

Advancing prostate MRI with quantitative diffusion biomarkers. OnQ™ Prostate brings objective RSI-based insights to support data-driven cancer evaluation.

Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
  • 2 mins

03/04/2026

Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies

NeuroQuant® Lesion Surveillance will be integrated into the Siemens Healthineers Digital Marketplace to advance quantitative brain imaging worldwide.

, ,

Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
  • 2 mins

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.

, ,

View our insights
Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study

Empowering precision

and clarity in patient care

727 Madison Ave, Suite 29, Covington, Kentucky 41011

Headquarters:

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
  • Solutions
  • © Cortechs.ai 2024
Scroll to Top